AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2015-074
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

NRSN2 Promotes Breast Cancer Metastasis by Activating PI3K/AKT/mTOR and NF‑κB Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2019English

Honokiol-Mediated Inhibition of PI3K/mTOR Pathway

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2009English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Activation of Autophagy During Farnesyl Pyrophosphate Synthase Inhibition Is Mediated Through PI3K/AKT/mTOR Signaling

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Contact-Dependent Inhibition of EGFR Signaling by Nf2/Merlin

Journal of Cell Biology
MedicineCell Biology
2007English

In Vitro Effects of PI3K/mTOR Inhibition in Canine Hemangiosarcoma

PLoS ONE
Multidisciplinary
2018English

Aberrant Overexpression of ADAR1 Promotes Gastric Cancer Progression by Activating mTOR/p70S6K Signaling

Oncotarget
Oncology
2016English

PI3K/mTOR Signaling in Mesothelioma Patients Treated With Induction Chemotherapy Followed by Extrapleural Pneumonectomy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy